Post-Translational Modification Inhibitors

 
Cat.No.
Product Name / Activity
1744 Bay 11-7821
E2 ubiquitin (Ub) conjugating enzymes inhibitor
4200 C 646
Selective p300/CBP inhibitor
4503 CC 0651
Allosteric inhibitor of hCdc34
3416 Tris DBA
N-myristoyltransferase-1 inhibitor; antiproliferative
5646 EML 425
Reversible and non-competitive p300/CBP inhibitor
2407 FTI 277
Prodrug form of FTI 276 (Cat. No. 2406)
2430 GGTI 298
Geranylgeranyltransferase I (GGTase I) inhibitor
2637 Gliotoxin
Farnesyltransferase and geranylgeranyltransferase I inhibitor
5045 L002
p300 inhibitor
4294 LB 42708
Selective farnesyltransferase (FTase) inhibitor
4993 NSC 624206
Ubiquitin-activating enzyme (E1) inhibitor
4858 NSC 697923
Selective UBE2N inhibitor
4903 NU 9056
Inhibitor of KAT5 (Tip60) histone acetyltransferase
2978 PYR 41
Ubiquitin-activating enzyme (E1) inhibitor
4994 PYZD 4409
Ubiquitin-activating enzyme (E1) inhibitor
5482 TDFA
PAD4 inhibitor

View all Post-Translational Modification products

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

LinkedIn Updates

Follow Tocris on LinkedIn

Follow us on LinkedIn!

Visit our LinkedIn page for the latest Tocris news, events and updates.